Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.5600 (8.43%) ($14.4800 - $15.7800) on Tue. Nov. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.89% (three month average) | RSI | 62 | Latest Price | $15.5600(8.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) IBB(45%) ARKG(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.945% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-8%) TLT(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.945% (StdDev 3.89%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.31(8.74%) | 10 Day Moving Average | $13.76(13.08%) | 20 Day Moving Average | $13.93(11.7%) | To recent high | -2% | To recent low | 30.5% | Market Cap | $1.156b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |